4th Quarter - Report
ARENTFOX SCHIFF LLP for SANOFI PASTEUR
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Childhood immunizations Flu vaccine and miscellaneous vaccination issues Economic stimulus funding for avian flu research and pandemic preparedness
Foreign entity interest: Sanofi-aventis Group, identified in a 7/15/05 information update to the LD-1, is interested in U.S. vaccination policies that may affect the business of its subsidiary sanofi pasteur.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DALE BUMPERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.